Conjugation with polyamines enhances the antitumor activity of naphthoquinones against human glioblastoma cells. Issue 6 (July 2018)

• Record Type: Journal Article
• Authors: Romão, Luciana; do Canto, Vanessa P.; Netz, Paulo A.; Moura-Neto, Vivaldo; Pinto, Ângelo C.; Follmer, Cristian
• Is Part Of: Anti-cancer drugs. Volume 29:Issue 6(2018)
• Publication Date: 2018-07
• Subjects: glioblastoma -- lapachol -- naphthoquinones -- polyamine-conjugates -- topoisomerase; Antineoplastic agents -- Periodicals; Cancer -- Chemotherapy -- Periodicals; Antineoplastic Agents -- therapeutic use -- Periodicals; Drug Therapy -- Periodicals; 616.994061
• DOI: 10.1097/CAD.0000000000000619
• Languages: English
• ISSNs: 0959-4973

Abstract

Abstract : Glioblastoma multiform (GBM) is the most common and devastating type of primary brain tumor, being considered the deadliest of human cancers. In this context, extensive efforts have been undertaken to develop new drugs that exhibit both antiproliferation and antimetastasis effects on GBM. 1, 4-Naphthoquinone (1, 4-NQ) scaffold has been found in compounds able to inhibit important biological targets associated with cancer, which includes DNA topoisomerase, Hsp90 and monoamine oxidase. Among potential antineoplastic 1, 4-NQs is the plant-derived lapachol (2-hydroxy-3-prenyl-1, 4-naphthoquinone) that was found to be active against the Walker-256 carcinoma and Yoshida sarcoma. In the present study, we examined the effect of polyamine (PA)-conjugated derivatives of lapachol, nor-lapachol and lawsone on the growth and invasion of the human GBM cells. The conjugation with PA (a spermidine analog) resulted in dose-dependent and time-dependent increase of cytotoxicity of the 1, 4-NQs. In addition, in-vitro inhibition of GBM cell invasion by lapachol was increased upon PA conjugation. Previous biochemical experiments indicated that these PA-1, 4-NQs are capable of inhibiting DNA human topoisomerase II-α (topo2α), a major enzyme involved in maintaining DNA topology. Herein, we applied molecular docking to investigate the binding of PA-1, 4-NQs to the ATPase site of topo2α. The most active molecules preferentially bind at the ATP-binding site of topo2α, which is energetically favored by the conjugation with PA. Taken together, these findings suggested that the PA-1, 4-NQ conjugates might represent potential molecules in the development of new drugs in chemotherapy for malignant brain tumors. Abstract : Supplemental Digital Content is available in the text.